- Patient Information:
Details with Side Effects
Deconsal® CT (phenylephrine hcl and pyrilamine maleate tannate chewable tablets) Tannate Chewable Tablets are indicated for the symptomatic relief of the coryza and nasal congestion associated with the common cold, sinusitis, allergic rhinitis and other upper respiratory tract infections. Appropriate therapy should be provided for the primary disease.
DOSAGE AND ADMINISTRATION
Deconsal® CT (phenylephrine hcl and pyrilamine maleate tannate chewable tablets) Tannate Chewable Tablets: Administer the recommended dose every 12 hours. 12 years and older - 1 to 2 tablets; 6 to 12 years of age - !4 to 1 tablet.
Deconsal® CT (phenylephrine hcl and pyrilamine maleate tannate chewable tablets) Tannate Chewable Tablets are available as grape-flavored, dye-free, mottled brown-colored, round, scored tablet imprinted with CC on one side and the score line on the other
NDC No.: 10122-202-10 - Bottles of 100 Chewable Tablets and NDC No.: 10122-202-02 single tablet sample pouches.
Store at controlled room temperature, 20o-25o C (68o -77° F). Dispense in a tight, light-resistant container (USP/NF) with a child-resistant closure.
Protect from moisture.
Manufactured for: Cornerstone BioPharma, Inc. Cary, NC 27518
Last reviewed on RxList: 5/5/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Deconsal CT Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.